People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Von Eschenbach: Former FDA commissioner Andrew von Eschenbach will split his time between MD Anderson and the regulatory consulting firm Greenleaf Health LLC, which he will join as senior advisor. He returns to the University of Texas MD Anderson Cancer Center in Houston as an adjunct professor and will also serve on the advisory board of the David Koch Center for Applied Research in Genitourinary Cancers. On the policy side, von Eschenbach says he will use Greenleaf Health as a "launching pad" to participate in the discussion of macro health issues like personalized medicine, genomics and informatics. Von Eschenbach resigned as FDA commissioner upon the inauguration of President Obama; his successor has not yet been named
You may also be interested in...
People In Brief
The latest moves by movers and shakers in the medical device and diagnostics industries
People In Brief
Schultz the consultant: Former CDRH Director Daniel Schultz has joined Greenleaf Health as senior VP for medical devices and combination products, the consulting firm announced Jan. 6. Schultz left the device center in August as the new FDA leadership reassessed past CDRH device review practices, which have come under intensifying public criticism (1"The Gray Sheet" Aug. 17, 2009). He had led the center for five years and worked at CDRH for 15 years. Greenleaf is developing into a regular landing spot for recently departed top FDA officials. Taryn Fritz Warpole, former deputy chief of staff, joined the firm in July and former Commissioner Andrew von Eschenbach signed on as a senior advisor in March (2"The Gray Sheet" March 9, 2009). Former FDA Chief of Staff Patrick Ronan founded the consulting practice
People In Brief
Schultz the consultant: Former CDRH Director Daniel Schultz has joined Greenleaf Health as senior VP for medical devices and combination products, the consulting firm announced Jan. 6. Schultz left the device center in August as the new FDA leadership reassessed past CDRH device review practices, which have come under intensifying public criticism (1"The Gray Sheet" Aug. 17, 2009). He had led the center for five years and worked at CDRH for 15 years. Greenleaf is developing into a regular landing spot for recently departed top FDA officials. Taryn Fritz Warpole, former deputy chief of staff, joined the firm in July and former Commissioner Andrew von Eschenbach signed on as a senior advisor in March (2"The Gray Sheet" March 9, 2009). Former FDA Chief of Staff Patrick Ronan founded the consulting practice